| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2B | $8.1B | $7.3B | $5.9B | $4.2B | $2.2B | $1.8B | $2.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.0B | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.7B | $0.6B | $0.5B | $2.1B | $0.3B | $-0.8B | $0.1B |
| EPS (Basic) | $6.40 | $6.31 | $5.74 | $4.71 | $17.92 | $2.03 | $-5.76 | $0.78 |
| EPS (Diluted) | $6.29 | $6.17 | $5.42 | $4.30 | $16.61 | $1.94 | $-5.45 | $0.76 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $178.9B | $163.9B | $157.1B | $147.7B | $171.3B | $180.5B | $169.1B | $154.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | $1.4B | $1.5B | $1.2B | $1.5B |
| Total Liabilities | $171.8B | $157.9B | $151.0B | $141.5B | $161.4B | $169.3B | $158.8B | $145.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.0B | $4.0B | $4.2B | $4.5B | $8.3B | $10.1B | $9.4B | $8.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.3B | $1.6B | $1.4B | $0.1B | $1.2B | $1.3B | $1.9B |
| Investing Cash Flow | $-1.4B | $0.5B | $2.5B | $-1.9B | $-0.3B | $-2.5B | $-1.3B | $-0.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | $-1.4B | $-4.1B | $0.0B | $-0.3B | $1.7B | $-0.1B | $-1.8B |